Hearts Without Borders
A donor-funded cardiac screening program bringing remote monitoring to people the health system has left behind—in the United States, conflict zones, and low- and middle-income countries.
Support the programHow it worksCardiac expertise, delivered anywhere.
Bukrah brings trusted medical access and on-the-ground continuity. Biotricity contributes clinical-grade devices, continuous ECG data, analytics, and qualified clinical interpretation. Together, the partnership can place a cardiologist’s judgment where a cardiologist cannot physically be.
Too often, the stroke becomes the diagnosis.
Atrial fibrillation can be silent, but it is highly treatable when found. Longer monitoring also identifies other actionable rhythm problems—including pauses, heart block, and ventricular arrhythmias—that short tests may miss.
The treatment is accessible. The test is simple. The failure is access.
One device. Patient after patient.
100% donor-funded and free to the patient.
Biotricity supplies
Devices, cloud analytics, and clinical over-read.
Bukrah deploys
Equipment reaches clinics, field sites, and medical delegations.
Patient is fitted
Trained local staff apply the device; no cardiologist is needed on site.
The heart is read
Recordings are analyzed and interpreted remotely.
The cycle repeats
The device is cleaned, reset, re-kitted, and used again.
Three channels. One protocol.
United States
32.4Mpatients already reached through health centers and free clinics, including millions living with hypertension or diabetes.
Conflict zones
38Mpeople within Bukrah’s operating footprint, where cardiac services may be severely limited or unavailable.
LMIC partners
~550Mpeople across proposed launch countries where the burden is high and specialist access is scarce.
Population and eligibility figures are program-planning estimates from the slide deck, not forecasts of patients reached.
What 100,000 screenings could do
These figures are illustrative projections based on a modeled clinical mix and published evidence. Actual outcomes will be measured and reported; they are not results already achieved by the program.
The measures that matter
Lives protected
Modeled and, as data matures, published estimates of strokes and sudden deaths prevented.
Care where there was none
Cardiologist-hours delivered to regions without specialist access.
Better lives lived
Years of disability-free life preserved and avoidable hospital visits prevented.
Diagnosis before catastrophe
Actionable findings identified before stroke, collapse, or another emergency.
For a person with silent atrial fibrillation, tomorrow is the whole point.
Help bring cardiac care within reachSources & methodology
Clinical detection and treatment evidence
The program model draws on peer-reviewed studies of extended cardiac monitoring, atrial fibrillation detection, post-stroke monitoring, dialysis populations, and anticoagulation outcomes listed in the original program deck.
Population, access, and cost evidence
Population and access figures draw on sources including HRSA health-center data, WHO resources, humanitarian health reports, and published stroke-cost research cited in the original program deck.
Important program disclaimer
This page describes a proposed donor-funded screening model. Impact and cost figures are estimates for planning and communication, not medical advice, guaranteed outcomes, or completed program results.